Leptin Receptor Gene Deficiency Minimally Affects Osseointegration in Rats

Overview

Journal Sci Rep

Specialty Science

Date 2023 Sep 20

PMID 37730735

Authors

Martina Jolic

Krisztina Ruscsak

Lena Emanuelsson

Birgitta Norlindh

Peter Thomsen

Furqan A Shah

Anders Palmquist

Affiliations

Soon will be listed here.

Abstract

Metabolic syndrome represents a cluster of conditions such as obesity, hyperglycaemia, dyslipidaemia, and hypertension that can lead to type 2 diabetes mellitus and/or cardiovascular disease. Here, we investigated the influence of obesity and hyperglycaemia on osseointegration using a novel, leptin receptor-deficient animal model, the Lund MetS rat. Machined titanium implants were installed in the tibias of animals with normal leptin receptor (LepR) and those harbouring congenic leptin receptor deficiency (LepR) and were left to heal for 28 days. Extensive evaluation of osseointegration was performed using removal torque measurements, X-ray micro-computed tomography, quantitative backscattered electron imaging, Raman spectroscopy, gene expression analysis, qualitative histology, and histomorphometry. Here, we found comparable osseointegration potential at 28 days following implant placement in LepR and LepR rats. However, the low bone volume within the implant threads, higher bone-to-implant contact, and comparable biomechanical stability of the implants point towards changed bone formation and/or remodelling in LepR rats. These findings are corroborated by differences in the carbonate-to-phosphate ratio of native bone measured using Raman spectroscopy. Observations of hypermineralised cartilage islands and increased mineralisation heterogeneity in native bone confirm the delayed skeletal development of LepR rats. Gene expression analyses reveal comparable patterns between LepR and LepR animals, suggesting that peri-implant bone has reached equilibrium in healing and/or remodelling between the animal groups.

References

Adell R, Lekholm U, Rockler B, Branemark P . A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg. 1981; 10(6):387-416. DOI: 10.1016/s0300-9785(81)80077-4. View

Shapses S, Pop L, Wang Y . Obesity is a concern for bone health with aging. Nutr Res. 2017; 39:1-13. PMC: 5385856. DOI: 10.1016/j.nutres.2016.12.010. View

Karim L, Bouxsein M . Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties. Bone. 2015; 82:21-7. PMC: 4679472. DOI: 10.1016/j.bone.2015.07.028. View

Palmquist A . A multiscale analytical approach to evaluate osseointegration. J Mater Sci Mater Med. 2018; 29(5):60. PMC: 5938308. DOI: 10.1007/s10856-018-6068-y. View

Unnanuntana A, Rebolledo B, Khair M, DiCarlo E, Lane J . Diseases affecting bone quality: beyond osteoporosis. Clin Orthop Relat Res. 2010; 469(8):2194-206. PMC: 3126973. DOI: 10.1007/s11999-010-1694-9. View

Yamamoto M, Yamauchi M, Sugimoto T . Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2013; 98(10):4030-7. DOI: 10.1210/jc.2013-2143. View

Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti M, Pulvirenti I . Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97(10):3744-50. DOI: 10.1210/jc.2012-1901. View

Wu Y, Xu S, Liu S, Xu L, Deng S, He Y . Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling. Eur Rev Med Pharmacol Sci. 2017; 21(3):470-478. View

Wijenayaka A, Kogawa M, Lim H, Bonewald L, Findlay D, Atkins G . Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One. 2011; 6(10):e25900. PMC: 3186800. DOI: 10.1371/journal.pone.0025900. View

10.

Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S . Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 2000; 191(2):275-86. PMC: 2195746. DOI: 10.1084/jem.191.2.275. View

11.

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

12.

Turcotte A, OConnor S, Morin S, Gibbs J, Willie B, Jean S . Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis. PLoS One. 2021; 16(6):e0252487. PMC: 8186797. DOI: 10.1371/journal.pone.0252487. View

13.

Chen J, Lazarenko O, Wu X, Tong Y, Blackburn M, Shankar K . Obesity reduces bone density associated with activation of PPARγ and suppression of Wnt/β-catenin in rapidly growing male rats. PLoS One. 2010; 5(10):e13704. PMC: 2965663. DOI: 10.1371/journal.pone.0013704. View

14.

Felice J, Gangoiti M, Molinuevo M, McCarthy A, Cortizo A . Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats. Metabolism. 2013; 63(2):296-305. DOI: 10.1016/j.metabol.2013.11.002. View

15.

Coelho P, Pippenger B, Tovar N, Koopmans S, Plana N, Graves D . Effect of Obesity or Metabolic Syndrome and Diabetes on Osseointegration of Dental Implants in a Miniature Swine Model: A Pilot Study. J Oral Maxillofac Surg. 2018; 76(8):1677-1687. PMC: 6064394. DOI: 10.1016/j.joms.2018.02.021. View

16.

King S, Tanaka C, Ross D, Kruzic J, Levinger I, Klineberg I . A diet high in fat and fructose adversely affects osseointegration of titanium implants in rats. Clin Exp Dent Res. 2020; 6(1):107-116. PMC: 7025982. DOI: 10.1002/cre2.255. View

17.

Caliaperoumal G, Souyet M, Bensidhoum M, Petite H, Anagnostou F . Type 2 diabetes impairs angiogenesis and osteogenesis in calvarial defects: MicroCT study in ZDF rats. Bone. 2018; 112:161-172. DOI: 10.1016/j.bone.2018.04.009. View

18.

Souto-Maior J, Pellizzer E, Gomes J, Dds C, Dds J, Vasconcelos B . Influence of Diabetes on the Survival Rate and Marginal Bone Loss of Dental Implants: An Overview of Systematic Reviews. J Oral Implantol. 2019; 45(4):334-340. DOI: 10.1563/aaid-joi-D-19-00087. View

19.

Albrektsson T, Johansson C . Osteoinduction, osteoconduction and osseointegration. Eur Spine J. 2001; 10 Suppl 2:S96-101. PMC: 3611551. DOI: 10.1007/s005860100282. View

20.

Hasegawa H, Ozawa S, Hashimoto K, Takeichi T, Ogawa T . Type 2 diabetes impairs implant osseointegration capacity in rats. Int J Oral Maxillofac Implants. 2008; 23(2):237-46. View